Brookfield Corp’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,651
Closed -$1.37M 731
2022
Q4
$1.37M Buy
+24,651
New +$1.26M 0.01% 464
2022
Q3
Sell
-38,102
Closed -$2.38M 714
2022
Q2
$2.38M Buy
38,102
+21,065
+124% +$1.49M 0.01% 383
2022
Q1
$1.39M Buy
17,037
+6,392
+60% +$497K 0.01% 453
2021
Q4
$931K Buy
10,645
+311
+3% +$25.9K ﹤0.01% 461
2021
Q3
$818K Buy
+10,334
New +$849K ﹤0.01% 443

Other funds holding LIVN

Brookfield Corp's LIVN Position: Q1 2023 in Review

Brookfield Corp sold out of LivaNova (LIVN) in Q1 2023, closing a stake of 24,651 shares — an estimated $1.37M sold.

Brookfield Corp first reported a position in LIVN in Q3 2021 and held it in 5 quarters. The position peaked at $2.38M in Q2 2022. 210 funds tracked by Wall St. Rank hold LIVN as of Q1 2023.

  • Brookfield Corp reported no remaining LivaNova position as of Q1 2023 after selling out during the quarter.
  • Brookfield Corp sold 24,651 LivaNova shares in Q1 2023, an estimated $1.37M.
  • Brookfield Corp first reported a position in LivaNova in Q3 2021 and held it in 5 quarters.
  • Brookfield Corp's LivaNova position peaked at $2.38M in Q2 2022.
  • 210 funds tracked by Wall St. Rank held LivaNova as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.